214 related articles for article (PubMed ID: 23007140)
1. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.
Oprescu N; McCormack FX; Byrnes S; Kinder BW
Lung; 2013 Feb; 191(1):35-42. PubMed ID: 23007140
[TBL] [Abstract][Full Text] [Related]
2. The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.
Gupta N; Lee HS; Ryu JH; Taveira-DaSilva AM; Beck GJ; Lee JC; McCarthy K; Finlay GA; Brown KK; Ruoss SJ; Avila NA; Moss J; McCormack FX;
Chest; 2019 Feb; 155(2):288-296. PubMed ID: 29940164
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.
Khawar MU; Yazdani D; Zhu Z; Jandarov R; Dilling DF; Gupta N
J Heart Lung Transplant; 2019 Sep; 38(9):949-955. PubMed ID: 31303421
[TBL] [Abstract][Full Text] [Related]
5. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish registry.
Antón E; Casanova A; Xaubet A; Román A; Villena V; Montero MC; Molina-Molina M; Pérez-Sánchez E; Sueiro A; Morell F; Girón RM; Ancochea J
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):85-91. PubMed ID: 20560288
[TBL] [Abstract][Full Text] [Related]
6. Emerging clinical picture of lymphangioleiomyomatosis.
Cohen MM; Pollock-BarZiv S; Johnson SR
Thorax; 2005 Oct; 60(10):875-9. PubMed ID: 16055626
[TBL] [Abstract][Full Text] [Related]
7. Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.
Maurer JR; Ryu J; Beck G; Moss J; Lee JC; Finlay G; Brown K; Chapman J; McMahan J; Olson E; Ruoss S; Sherer S;
J Heart Lung Transplant; 2007 Dec; 26(12):1293-9. PubMed ID: 18096481
[TBL] [Abstract][Full Text] [Related]
8. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.
Kpodonu J; Massad MG; Chaer RA; Caines A; Evans A; Snow NJ; Geha AS
J Heart Lung Transplant; 2005 Sep; 24(9):1247-53. PubMed ID: 16143241
[TBL] [Abstract][Full Text] [Related]
9. [Lung transplantation in sporadic lymphangioleiomyomatosis: study of 7 cases].
Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J
Med Clin (Barc); 2013 Oct; 141(8):349-52. PubMed ID: 23937818
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis.
Salman J; Ius F; Sommer W; Siemeni T; Fleissner F; Alhadidi H; Kugler C; Avsar M; Haverich A; Warnecke G; Tudorache I; Kuhn C
Prog Transplant; 2019 Jun; 29(2):115-121. PubMed ID: 31084354
[TBL] [Abstract][Full Text] [Related]
11. Lung transplantation for lymphangioleiomyomatosis: the European experience.
Benden C; Rea F; Behr J; Corris PA; Reynaud-Gaubert M; Stern M; Speich R; Boehler A
J Heart Lung Transplant; 2009 Jan; 28(1):1-7. PubMed ID: 19134523
[TBL] [Abstract][Full Text] [Related]
12. [Sporadic lymphangioleiomyomatosis. Clinical and lung functional characteristics of 32 female patients].
Watz H; Oltmanns A; Kimmel S; Magnussen H; Wirtz H; Kirsten D
Dtsch Med Wochenschr; 2008 Apr; 133(14):705-8. PubMed ID: 18363188
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of 280 hospitalized patients with lymphangioleiomyomatosis in Japan.
Hasegawa W; Yamauchi Y; Yasunaga H; Sunohara M; Jo T; Matsui H; Fushimi K; Takami K; Nagase T
Respirology; 2015 Jan; 20(1):160-5. PubMed ID: 25385157
[TBL] [Abstract][Full Text] [Related]
14. Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization.
Kristof AS; Zhi Li P; Major P; Landry JS
Chest; 2015 Aug; 148(2):444-449. PubMed ID: 25789699
[TBL] [Abstract][Full Text] [Related]
15. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
[TBL] [Abstract][Full Text] [Related]
16. Lymphangioleiomyomatosis.
Johnson SR
Eur Respir J; 2006 May; 27(5):1056-65. PubMed ID: 16707400
[TBL] [Abstract][Full Text] [Related]
17. Survival and disease progression in UK patients with lymphangioleiomyomatosis.
Johnson SR; Whale CI; Hubbard RB; Lewis SA; Tattersfield AE
Thorax; 2004 Sep; 59(9):800-3. PubMed ID: 15333859
[TBL] [Abstract][Full Text] [Related]
18. Lymphangioleiomyomatosis and pregnancy: a mini-review.
Zhou J; Diao M
Arch Gynecol Obstet; 2024 Jun; 309(6):2339-2346. PubMed ID: 38594407
[TBL] [Abstract][Full Text] [Related]
19. Canadian respirologists' experience with lymphangioleiomyomatosis.
Pollock-BarZiv SM; Cohen MM; Maclean H; Downey GP
Can Respir J; 2002; 9(6):413-6. PubMed ID: 12522487
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
Moss J; Avila NA; Barnes PM; Litzenberger RA; Bechtle J; Brooks PG; Hedin CJ; Hunsberger S; Kristof AS
Am J Respir Crit Care Med; 2001 Aug; 164(4):669-71. PubMed ID: 11520735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
